Here are the 424B prospectus supplements from Innoviz Technologies Ltd. (INVZ) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow INVZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INVZ filings page.
Innoviz Technologies Ltd. is conducting a primary offering of 66,666,667 ordinary shares at $0.45 per share under its shelf registration, for gross proceeds of $30,000,000.15. After placement fees and estimated expenses, Innoviz expects net proceeds of about $27.3 million, to be used for general business purposes.
Shares outstanding will rise from 221,365,334 to 288,032,001, increasing cash and shareholders’ equity and causing immediate dilution: adjusted net tangible book value is expected to move from $0.27 to $0.30 per share, versus the $0.45 offering price, implying dilution of $0.15 to new investors. The company highlights risks including potential future equity offerings, the possibility of being treated as a PFIC for U.S. tax purposes, and a Nasdaq minimum bid price deficiency notice with a grace period through September 21, 2026, which could lead to delisting if not cured.